- $3.95bn
- $24.78bn
- $17.02bn
- 31
- 96
- 47
- 60
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,886 | 1,888 | 1,986 | 1,998 | 17,016 |
Cost of Revenue | |||||
Gross Profit | 1,099 | 1,144 | 1,202 | 1,136 | 5,070 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,813 | 1,775 | 1,824 | 1,808 | 17,260 |
Operating Profit | 73.1 | 112 | 162 | 190 | -245 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -93.2 | -27.8 | 128 | 233 | -1,932 |
Provision for Income Taxes | |||||
Net Income After Taxes | -114 | -51.9 | 62.7 | 167 | -1,635 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -62.9 | -40.1 | 72.9 | 177 | -1,702 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -62.9 | -40.1 | 72.9 | 177 | -1,702 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.06 | -0.388 | 1.11 | 2.11 | -4.54 |